17 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33525941 | Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release. | 2021 Dec | 1 |
2 | 25360162 | Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study. | 2014 | 1 |
3 | 23254592 | Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia. | 2013 Jul | 1 |
4 | 23150952 | Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? | 2012 Nov 14 | 1 |
5 | 19131462 | Antidiabetic action of bezafibrate in a large observational database. | 2009 Apr | 1 |
6 | 16606809 | Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. | 2006 Apr 10 | 1 |
7 | 12733699 | Bezafibrate improves hypertension and insulin sensitivity in humans. | 2003 Apr | 2 |
8 | 12754275 | Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy. | 2003 Aug | 1 |
9 | 11893366 | Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. | 2002 Mar | 1 |
10 | 12472919 | Bezafibrate-induced improvement in glucose uptake and endothelial function in protease inhibitor-associated insulin resistance. | 2002 Dec | 2 |
11 | 11288046 | Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. | 2001 Apr | 2 |
12 | 10868845 | Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients. | 2000 Feb | 1 |
13 | 10403804 | Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats. | 1999 Jul 5 | 1 |
14 | 9381994 | Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients. | 1997 Oct 1 | 1 |
15 | 7851275 | Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance. | 1994 Oct | 2 |
16 | 1458771 | Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia. | 1992 Dec | 1 |
17 | 2653325 | Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes. | 1989 Feb | 1 |